Patient Dies in Bristol Myers Squibb Study of Experimental Cell Therapy for Multiple Sclerosis
The company said the patient died of septic pneumonia 44 days after receiving zola-cel, an experimental CAR T therapy, and no other deaths have been reported in its autoimmune programs.
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
A patient with multiple sclerosis died of septic pneumonia 44 days after…
More reporting and context continue here.
The complete story is available with Premium.
Read the facts, open questions and supporting sources.
Continue reading with NewsPlain Premium.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.